4.7 Article

Structure-Activity Relationship Studies of Tolfenpyrad Reveal Subnanomolar Inhibitors of Haemonchus contortus Development

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 62, Issue 2, Pages 1036-1053

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b01789

Keywords

-

Funding

  1. Australian Research Council (ARC)
  2. Medicines for Malaria Venture (MMV)
  3. National Health and Medical Research Council of Australia (NHMRC) [1020411, 1117602]
  4. Therapeutic Innovation Australia (TIA)
  5. Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program
  6. Yourgene Bioscience
  7. National Health and Medical Research Council of Australia [1117602] Funding Source: NHMRC

Ask authors/readers for more resources

Recently, we have discovered that the registered pesticide, tolfenpyrad, unexpectedly and potently inhibits the development of the L4 larval stage of the parasitic nematode Haemonchus contortus with an IC50 value of 0.03 mu M while displaying good selectivity, with an IC50 of 37.9 mu M for cytotoxicity. As a promising molecular template for medicinal chemistry optimization, we undertook anthelmintic structure-activity relationships for this chemical. Modifications of the left-hand side (LHS), right-hand side (RHS), and middle section of the scaffold were explored to produce a set of 57 analogues. Analogues 25, 29, and 33 were shown to be the most potent compounds of the series, with IC50 values at a subnanomolar level of potency against the chemotherapeutically relevant fourth larval (L4) stage of H. contortus. Selected compounds from the series also showed promising activity against a panel of other different parasitic nematodes, such as hookworms and whipworms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available